Should you buy, hold, or sell these ASX 200 stars of FY25?

After exceptional share price growth, should you hold on to your outperformers or take your profits while the going is good?

A woman has a quizzical look on her face as though she is deciding something in the foreground of a backdrop featuring five stars, like the Australian five star energy rating system.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's a question that many S&P/ASX 200 Index (ASX: XJO) shares investors would be familiar with.

After exceptional share price growth, should you hold on to your outperformers or take your profits while the going is good?

The following four ASX 200 stocks delivered strong share price gains in FY25.

Market analysts tell us what they think investors should do with these holdings now.

After amazing growth, should you hang on to these ASX 200 stocks?

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price rose by 30% in FY25.

On Tuesday, Wesfarmers shares are 1.64% higher at $86.63 at the time of writing.

Macquarie has a neutral rating on Wesfarmers shares and a price target of $82. This is akin to a hold rating.

In a recent note, Macquarie said:

Management continues to execute, with the stock's valuation continuing to be driven by the key Bunnings and Kmart retail businesses.

We acknowledge the upside risk from new adjacencies, although see much of this factored into the current share price.

Sigma Healthcare (ASX: SIG)

In FY25, Sigma Healthcare was one of nine ASX 200 shares that more than doubled in value. 

The ASX healthcare stock ripped 135% higher in FY25.

Today, the Sigma Healthcare share price is down 0.35% to $2.86 at the time of writing.

Macquarie has an underperform rating on Sigma Healthcare shares.

The broker explains:

We retain our Underperform recommendation on SIG as we believe the market is giving too much credit on growth prospects (although we still expect sector leading earnings growth).

The first result as a combined entity with Chemist Warehouse will be telling on growth potential and franchisee economics.

Sigma Healthcare will report its results on Wednesday, 27 August.

Hub24 Ltd (ASX: HUB)

Hub24 shares were among the 5 best ASX 200 financial stocks of FY25 for share price growth.

Shares in the investment and superannuation platform provider rose 92% in FY25.

The Hub24 share price is currently $108.11, up 1.26%.

Bell Potter has a buy rating on Hub24 with a 12-month price target of $115.

This implies further potential upside of 6%.

Xero Ltd (ASX: XRO)

Xero shares were among the 5 best-performing ASX 200 tech shares of FY25.

Shares in the cloud-based accounting software provider rose 32% in FY25.

The Xero share price is currently $177.55, up 1.25%.

Morgans has a hold rating on this ASX 200 tech stock.

Analyst Damien Nguyen suggests that new investors wait for a dip before buying Xero shares.

Nguyen commented on The Bull:

While business fundamentals remain solid and are expected to deliver strong growth over the coming years, potential investors may want to wait for a more attractive entry point.

For existing holders, it makes sense to stay invested and monitor how the company executes its growth plans.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24, Macquarie Group, Wesfarmers, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group and Xero. The Motley Fool Australia has recommended Hub24 and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

two people sit side by side on a rollercoaster ride with their hands raised in the air and happy smiles on their faces
Opinions

Up over 200% in 6 months: Are Pilbara Minerals shares still a buy?

How high can the lithium producer’s shares go?

Read more »

Two young boys sit at a desk wearing helmets with lightbulbs, indicating two ASX 200 shares that a broker has recommended as buys today
Opinions

The best stocks to invest $1,000 in right now

I'd be happy to pick up more of these winners right now.

Read more »

A woman sits on sofa pondering a question.
Opinions

Best ASX retail stock to buy right now: Wesfarmers or Woolworths?

Here's my pick between the two retail powerhouses.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Opinions

4 ASX shares I'd buy today with $10,000

I think these shares are set to soar.

Read more »

A man in his 30s with a clipped beard sits at his laptop on a desk with one finger to the side of his face and his chin resting on his thumb as he looks concerned while staring at his computer screen.
Opinions

Is it time to sell your Wesfarmers shares?

The stock crashed 15% in October.

Read more »

A woman looks nonplussed as she holds up a handful of Australian $50 notes.
Opinions

Westpac versus CBA shares: Which bank is a better buy for 2026?

Are you weighing up buying shares in these two banking giants?

Read more »

A woman sits on a chair smiling as she shops online.
Opinions

Down 30% this year. Are Block shares finally a buy?

Here's what's ahead for the company over the next 12 months.

Read more »

A trendy woman wearing sunglasses splashes cash notes from her hands.
Opinions

3 of the best ASX 200 shares to buy right now!

These stocks have strong long-term growth potential.

Read more »